US · Healthcare

Northwest Biotherapeutics Inc (NWBO)

Biotechnology

Northwest Biotherapeutics Inc (NWBO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NWBO

P/E ratio

18.00

Northwest Biotherapeutics Inc (NWBO) — FAQ

What is NWBO's P/E ratio?

The price-to-earnings (P/E) ratio for Northwest Biotherapeutics Inc (NWBO) is 18.00 (data as of 2026-03-24).

Does Northwest Biotherapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Northwest Biotherapeutics Inc (NWBO). Check the MyAverix Finance app for the latest dividend data.

What sector is Northwest Biotherapeutics Inc in?

Northwest Biotherapeutics Inc (NWBO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NWBO listed on?

NWBO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)